underperform rating

Credit Suisse says that although the regulatory environment favours wind power.Infigen has locked in purchase agreements that are unlikely to capture much upside. Although Infigen is repositioning itself, its strategy is untested and it has no clear development plan for the Australian assets so growth from value-adding wind developments appears to be post 2011 and Credit Suisse therefore rates the stock underperform.Credit Suisse also says that since ORG announced its wind development pipeline, the notion of Infigen having a strong market position is questionable.

Others state that the wind power business is in turnaround mode and facing pressure from key investors to sell assets and distribute the money. Infigen's market position could be vulnerable and it still needs to source attractive funding for its developments.